Lupin Ltd is working on acquiring licenses and partnerships for various Covid-19 drugs and vaccines, chief executive officer Vinita Gupta said, after the drugmaker missed...
Lupin Ltdβs stake sale in its Japanese subsidiaryΒ Kyowa PharmaΒ has provided a dose of optimism to investors. The sale is expected to free-up capital that will...
Lupin Ltd reported an unanticipated quarterly loss after registering a one-time charge related to litigation over a blood pressure drug. Indian drugmaker created a provision...